Literature DB >> 19350353

Malignant phyllodes tumor composed almost exclusively of a fibrosarcomatous component: a case report and review of malignant phyllodes tumors with metastases.

Satomi Suzuki-Uematsu1, Kazuko Shiraishi, Taro Ito, Naoki Adachi, Yoshihisa Inage, Yoshinori Taeda, Hamaichi Ueki, Haruo Ohtani.   

Abstract

Here we present a case of malignant phyllodes tumor which was composed almost exclusively of a fibrosarcomatous component. A 52-year-old Japanese female noted a rapid increase of her right breast tumor. On admission, multiple lung metastases were detected by imaging. Right simple mastectomy was performed. The tumor, 10 x 10 cm in the largest dimension, had somewhat of a pushing margin, and showed a flesh-like appearance with marked necrosis. Microscopically, the tumor showed proliferation of atypical ovoid- or spindle-shaped cells in a myxoid matrix. Multiple sectioning revealed that the tumor had only focal occurrence of elongated tubular structures, and the occurrence of a small component of benign phyllodes tumor, leading to the aforementioned final diagnosis. Spindle cell carcinoma was excluded on the basis of the HE findings and the lack of immunoreactivity for cytokeratin when using a broad spectrum antibody mixture. Although the patient received adjuvant chemotherapy, no responsiveness was obtained. The patient died 4 months following surgery. We reviewed 15 malignant phyllodes tumors with metastases reported in Japan. The estimated 2.2-year survival rate following detection of metastasis was 11%, thus confirming the aggressiveness of the disease.

Entities:  

Mesh:

Year:  2009        PMID: 19350353     DOI: 10.1007/s12282-009-0099-7

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  11 in total

1.  Phyllodes Tumor of the Breast: Analysis of 48 Patients.

Authors:  Murat Özgür Kılıç; Serdar Gökay Terzioğlu; Betül Bozkurt; Gül Dağlar
Journal:  J Breast Health       Date:  2016-10-01

2.  A Phyllodes-like Mammary Tumor in a Breeding Galago (Otolemur garnettii).

Authors:  Carissa P Jones; Troy M Apple; Bryce J Burton; Melinda E Sanders; Kelli L Boyd; Kenneth J Salleng
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

Review 3.  Unusual aggressive breast cancer: metastatic malignant phyllodes tumor.

Authors:  Adam Singer; Jonathan Tresley; Jose Velazquez-Vega; Monica Yepes
Journal:  J Radiol Case Rep       Date:  2013-02-01

4.  How to approach phyllodes tumors of the breast?

Authors:  Turan Acar; Ercüment Tarcan; Mehmet Hacıyanlı; Erdinç Kamer; Mustafa Peşkersoy; Seyran Yiğit; Özlem Gür; Necat Cin; Ayşegül Akder Sarı; Fatma Tatar
Journal:  Ulus Cerrahi Derg       Date:  2015-06-24

5.  Phyllodes Tumors of the Breast: A Single-Center Experience.

Authors:  Sevda Yılmaz; Muhammed Rasid Aykota; Yeliz Arman Karakaya; Utku Özgen; Ergün Erdem
Journal:  Eur J Breast Health       Date:  2020-12-24

6.  Predictive Factors of Early Recurrence in Patients with Phyllodes Tumor of the Breast.

Authors:  Bharadhwaj Ravindhran; Sendhil Rajan
Journal:  Eur J Breast Health       Date:  2020-12-24

7.  Aggressive palliative surgery in metastatic phyllodes tumor: impact on quality of life.

Authors:  A S Kapali; M Singh; Svs Deo; N K Shukla; Dillip K Muduly
Journal:  Indian J Palliat Care       Date:  2010-05

Review 8.  Malignant phyllodes tumor of the breast: a systematic review.

Authors:  Germana Lissidini; Antonino Mulè; Angela Santoro; Giovanni Papa; Luca Nicosia; Enrico Cassano; Arwa Ahmed Ashoor; Paolo Veronesi; Liron Pantanowitz; Jason L Hornick; Esther Diana Rossi
Journal:  Pathologica       Date:  2022-04-13

9.  Osteoclastic giant cell rich metaplastic carcinoma in malignant phylloides: A rare entity.

Authors:  Yasmin A Momin; Bhavana M Bharambe; Sameer Ah Ansari; Bharat A Ghodke
Journal:  South Asian J Cancer       Date:  2012-10

10.  Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities.

Authors:  Denis L Fontes Jardim; Anthony Conley; Vivek Subbiah
Journal:  Orphanet J Rare Dis       Date:  2013-07-30       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.